Is Denali Therapeutics (DNLI) the Most Promising Mid-Cap Healthcare Stock Under $50?

Denali Therapeutics (NASDAQ:DNLI) is one of the most promising mid-cap healthcare stocks under $50. On December 11, Wedbush analyst Laura Chico maintained her bullish stance on Denali Therapeutics (NASDAQ:DNLI). She rated the stock Buy with a $30 target price, implying a notable 78% upside for investors. Iakov Filimonov/Shutterstock.com Chico’s price target is a revision from the previous target of $31, but this comes after the company’s completion of a recent $200 million secondary offering. The compa ...